Skip to main content

Hyaluronic Acid Based Dermal Fillers Market Size to Surpass USD 7.15 Billion by 2030, at a CAGR of 8.1%

As per the report by Fortune Business Insights, The Hyaluronic Acid Based Dermal Fillers Market is projected to grow from USD 4.13 billion in 2023 to USD 7.15 billion by 2030, exhibiting a CAGR of 8.1% during the forecast period.

Pune, India, June 28, 2023 (GLOBE NEWSWIRE) — The global hyaluronic acid based dermal fillers market size was valued at USD 3.88 billion in 2022. The market is projected to grow from USD 4.13 billion in 2023 to USD 7.15 billion by 2030, exhibiting a CAGR of 8.1% during the forecast period.

This information is provided by Fortune Business Insights, in its report, titled, “Hyaluronic Acid Based Dermal Fillers Market, 2023-2030.”

Request a Free Sample PDF:

https://www.fortunebusinessinsights.com/enquiry/sample/hyaluronic-acid-based-dermal-fillers-market-100951


Key Industry Development:

May 2021: Sinclair Pharma unveiled a novel hyaluronic acid (HA) facial filler termed MaiLi. The company announced that MaiLi has four products in its portfolio – Precise, Volume, Define, as well as Extreme.

Key Takeaways:

  • COVID-19 Pandemic Slowed Market Growth in 2020 due to Shutdown of Dermatology Clinics
  • Rising Demand for Hyaluronic Acid Based Dermal Fillers Among Young Adults to Boost Market Growth
  • Increasing Demand for Minimally Invasive Facial Treatments Worldwide to Boost Market Growth
  • Growing HA-based Dermal Fillers Procedures and Introduction of Products to Propel Market
  • Presence of Alternative Dermal Fillers to Hamper the Market Growth

List of Key Players Mentioned in the Report:

  • Allergan Aesthetics (AbbVie Inc.) (U.S.)
  • Revance Therapeutics, Inc. (U.S.)
  • Merz Pharma (Germany)
  • Galderma (Switzerland)
  • Sinclair Pharma (U.K.)
  • BIOPLUS CO., LTD. (South Korea)
  • Bioxis Pharmaceuticals (France)
  • DR. Korman (Israel)
  • Prollenium Medical Technologies (Canada)
  • Teoxane (Switzerland)


Report Scope & Segmentation:

Report Coverage Details
Forecast Period 2023 to 2030
Forecast Period 2023 to 2030 CAGR 8.1%
2030 Value Projection USD 7.15 Billion
Base Year 2022
Hyaluronic Acid Based Dermal Fillers Market Size in 2022 USD 3.88 Billion
Historical Data for 2019 to 2021
No. of Pages 177
Segments covered By Crosslinking Type, Application and End User


COVID-19 Impacts:

COVID-19 Reduced Market Growth in 2020 Backed by Shutting of Dermatology Centers

The impact of COVID-19 witnessed an outcome of lowered demand for HA-based dermal fillers in 2020. This is credited to the withdrawals in dermal fillers surgeries and decreased admission rate for anti-aging treatment during the pandemic. The widened interruption commenced due to COVID-19 has considerably influenced the production processes of raw hyaluronic acid. The announcement of lockdown in mostly affected spaces resulted in a standstill in the supply chains of dermal fillers, thereby perceiving a consequence of fall in sales.


To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:

https://www.fortunebusinessinsights.com/industry-reports/hyaluronic-acid-based-dermal-fillers-market-100951


Drivers and Restraints:

Rising Demand for Minimally Invasive Facial Treatments to Augur Market Growth

The requirement for anti-aging cosmetic therapies has augmented as the global population has matured. Hyaluronic acid based dermal fillers are vastly commended owing to their moisturizing and viscoelastic properties in minimally invasive anti-aging operations. The increasing interest among people for firmer-looking and ideal skin through non-invasive dermatology processes is anticipated to amplify the minimally-invasive aesthetic techniques utilizing hyaluronic acid fillers, thus fueling the global hyaluronic acid based dermal fillers market growth.

Segments:

Monophasic Segment to Hold a Prime Share due to its Rising Acceptance in Dermal Fillers Procedures

Based on crosslinking type, the market is segmented into monophasic and biphasic. In 2022, the monophasic segment held the highest market share and is predicted to extend at the greatest CAGR during the forecast period, 2023-2030.

Wrinkle Correction Treatment to Hold Lion’s Share Owing to Growing Implementation in Dermal Fillers Procedures

Based on application, the market is segmented into scar treatment, wrinkle correction treatment, lip enhancement, restoration of volume/fullness, and others. The wrinkle correction treatment segment is projected to grow at the highest CAGR during the forecast period, 2023-2030.

Quick Buy – Hyaluronic Acid Based Dermal Fillers Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/100951


Specialty & Dermatology Clinics Segment to Maintain Domination Owing to Surging Patient Appointments

Based on end-user, the market is segmented into specialty & dermatology clinics, hospitals & clinics, and others. The specialty & dermatology clinics segment held the greatest market share in 2022 and is predicted to expand at the highest CAGR during the forecast period. Geographically, the market is segregated into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Report Coverage:

The report presents a holistic study of the market for hyaluronic acid based dermal fillers along with current trends and future anticipations to establish proximate investment gains. An in-depth analysis of any upcoming opportunities, threats, competitions or driving factors is also mentioned in the report.

Regional Insights:

North America to Lead Stoked by Established Healthcare Infrastructure

North America held the largest hyaluronic acid based dermal fillers market share and was valued at USD 1.77 billion in 2021. It is predicted to grow at a notable CAGR during the forecast period. The growth is owing to the prompt acceptance of monophasic, well-settled healthcare infrastructure, and expansive R&D initiatives by dominating players.

Europe is projected to expand at a notable CAGR during the forecast timeframe. The growth is owing to the rising demand for anti-aging procedures utilizing HA-based fillers, owing to increasing aging populace.

The market in Asia Pacific is anticipated to grow at the largest CAGR during the forecast period. The market growth across the region is attributed to the rising consciousness concerning the usage of HA-based dermal fillers and the augmenting emphasis on enhancing hospital infrastructure.

Competitive Landscape:

Innovative Product Launch Announcement by Key Players to Bolster Market Growth

The prominent players adopt several strategies to bolster their position in the market as leading companies. One such key strategy is acquiring companies to bolster the brand value among users. Another essential strategy is periodically launching innovative products with a detailed study of the market and its target audience.

Ask for Customization of this Report:

https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/hyaluronic-acid-based-dermal-fillers-market-100951


Table Of Content :

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
    • Market Trends
  • Key Insights
    • Overview of the Number of Hyaluronic Acid Based Dermal Fillers Procedures by Key Countries
    • Overview of Regulatory Scenario by Key Countries
    • Overview of Reimbursement Scenario by Key Countries
    • New Product Launches
    • Pipeline Analysis
    • Key Industry Developments
    • Supply Chain Analysis
    • Pricing of Key Brands, By Region
    • Insights: Technical Challenges Regarding Commercialization of HA Based Dermal Fillers
    • Manufacturing Locations for Key Brands
    •  Impact of COVID-19 on the Market
  • Global Hyaluronic Acid Based Dermal Fillers Market Analysis, Insights and Forecast, 2019-2030
    • Market Analysis, Insights and Forecast – By Crosslinking Type
      •  Monophasic
      •  Biphasic
    • Market Analysis, Insights and Forecast – By Application
      •  Scar Treatment
      •  Wrinkle Correction Treatment
      •  Lip Enhancement
      •  Restoration of Volume/ Fullness
      •  Others
    • Market Analysis, Insights and Forecast – By End-user
      •  Specialty & Dermatology Clinics
      •  Hospitals & Clinics
      •  Others
    • Market Analysis, Insights and Forecast – By Region
      •  North America
      •  Europe
      •  Asia Pacific
      •  Latin America
      •  Middle East & Africa
  • North America Hyaluronic Acid Based Dermal Fillers Market Analysis, Insights and Forecast, 2019-2030
    • Market Analysis, Insights and Forecast – By Crosslinking Type
      •  Monophasic
      •  Biphasic
    • Market Analysis, Insights and Forecast – By Application
      •  Scar Treatment
      •  Wrinkle Correction Treatment
      •  Lip Enhancement
      •  Restoration of Volume/ Fullness
      •  Others
    • Market Analysis, Insights and Forecast – By End-user
      •  Specialty & Dermatology Clinics
      •  Hospitals & Clinics
      •  Others
    • Market Analysis, Insights and Forecast – By Country
      •  U.S.
        •  By Application
      •  Canada
        •  By Application

Toc Continue…


Related Reports:

Liver Cancer Therapeutics Market Size, Share & Report [2020-2027]

Neurovascular Devices Market Size, Share | Growth Report 2030

Orthokeratology Lens Market Growth & Share | Forecast [2029]

AI in Healthcare Market Size, Share & Industry Report, 2029

Healthcare Predictive Analytics Market | Research Report [2029]


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.